Similar articles for PMID: 17465234

Year	Number of Results
1988	1
1989	2
1994	1
1997	1
1998	1
1999	2
2000	1
2001	3
2002	11
2003	11
2004	13
2005	9
2006	8
2007	13
2008	6
2009	2
2010	3
2011	3
2012	2
2013	1
2014	1
2015	1
2017	1
2018	1
2019	3
2020	1
2022	1
2025	0

1

Multicenter phase II study of irinotecan plus bolus fluorouracil/l-leucovorin for metastasic colorectal cancer.

Mishima H, Ikenaga M, Ishida H, Iwamoto S, Morimoto T, Narahara H, Kato T, Tsujie M, Kitai T, Fukunaga M, Nakanishi M, Tsujinaka T, Furukawa H, Taguchi T; Osaka Gastrointestional Cancer Chemotherapy Study Group. Mishima H, et al. Anticancer Res. 2007 Mar-Apr;27(2):1003-8. Anticancer Res. 2007. PMID: 17465234 Free article. Clinical Trial.

2

Phase I/II study of irinotecan, 5-fluorouracil, and l-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer.

Goto A, Yamada Y, Hosokawa A, Ura T, Arai T, Hamaguchi T, Muro K, Shimada Y, Shirao K. Goto A, et al. Int J Clin Oncol. 2004 Oct;9(5):364-8. doi: 10.1007/s10147-004-0407-3. Int J Clin Oncol. 2004. PMID: 15549585 Clinical Trial.

3

Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.

Yoshino T, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamaguchi Y, Hasuike N, Yamazaki K, Machida N, Ono H. Yoshino T, et al. Jpn J Clin Oncol. 2007 Sep;37(9):686-91. doi: 10.1093/jjco/hym091. Epub 2007 Aug 24. Jpn J Clin Oncol. 2007. PMID: 17720736

4

Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancer.

Glimelius B, Ristamäki R, Kjaer M, Pfeiffer P, Skovsgaard T, Tveit KM, Linné T, Frödin JE, Boussard B, Oulid-Aïssa D, Pyrhönen S. Glimelius B, et al. Ann Oncol. 2002 Dec;13(12):1868-73. doi: 10.1093/annonc/mdf324. Ann Oncol. 2002. PMID: 12453854 Free article. Clinical Trial.

5

Phase II study of gefitinib, fluorouracil, leucovorin, and oxaliplatin therapy in previously treated patients with metastatic colorectal cancer.

Kuo T, Cho CD, Halsey J, Wakelee HA, Advani RH, Ford JM, Fisher GA, Sikic BI. Kuo T, et al. J Clin Oncol. 2005 Aug 20;23(24):5613-9. doi: 10.1200/JCO.2005.08.359. J Clin Oncol. 2005. PMID: 16110021 Clinical Trial.

6

Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.

Kemeny N, Garay CA, Gurtler J, Hochster H, Kennedy P, Benson A, Brandt DS, Polikoff J, Wertheim M, Shumaker G, Hallman D, Burger B, Gupta S. Kemeny N, et al. J Clin Oncol. 2004 Dec 1;22(23):4753-61. doi: 10.1200/JCO.2004.03.119. J Clin Oncol. 2004. PMID: 15570076 Clinical Trial.

7

Two different schedules of irinotecan (CPT-11) in patients with advanced colorectal carcinoma relapsing after a 5-fluorouracil and leucovorin combination. A randomized study.

Tsavaris N, Ziras N, Kosmas C, Giannakakis T, Gouveris P, Vadiaka M, Dimitrakopoulos A, Karadima D, Rokana S, Papalambros E, Papastratis G, Margaris H, Tsipras H, Polyzos A. Tsavaris N, et al. Cancer Chemother Pharmacol. 2003 Dec;52(6):514-9. doi: 10.1007/s00280-003-0659-z. Epub 2003 Sep 23. Cancer Chemother Pharmacol. 2003. PMID: 14504920 Clinical Trial.

8

Sequence effect of irinotecan and fluorouracil treatment on pharmacokinetics and toxicity in chemotherapy-naive metastatic colorectal cancer patients.

Falcone A, Di Paolo A, Masi G, Allegrini G, Danesi R, Lencioni M, Pfanner E, Comis S, Del Tacca M, Conte P. Falcone A, et al. J Clin Oncol. 2001 Aug 1;19(15):3456-62. doi: 10.1200/JCO.2001.19.15.3456. J Clin Oncol. 2001. PMID: 11481350 Clinical Trial.

9

A phase II study of irinotecan alternated with a weekly schedule of high-dose leucovorin and 48-hour 5-fluorouracil infusion in patients with metastatic colorectal cancer.

Rosati G, Rossi A, Reggiardo G, Manzione L. Rosati G, et al. Oncology. 2002;62(3):209-15. doi: 10.1159/000059567. Oncology. 2002. PMID: 12065867 Clinical Trial.

10

A randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer.

Underhill C, Goldstein D, Gorbounova VA, Biakhov MY, Bazin IS, Granov DA, Hossain AM, Blatter J, Kaiser C, Ma D. Underhill C, et al. Oncology. 2007;73(1-2):9-20. doi: 10.1159/000120626. Epub 2008 Mar 11. Oncology. 2007. PMID: 18334829 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 17465234

99 results

Results by year